19 May 2013
Keywords: fda, de, facto, ban, dual, trademarks, drugs
Article | 12 May 2003
For the US Food and Drug Administration to prohibit, de facto, dualtrade marks for drugs would be unflexible, unwise, detrimental ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 May 2003
17 May 2013
© 2013 thepharmaletter.com